Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;32(7):4457-4467.
doi: 10.1007/s00330-022-08589-7. Epub 2022 Mar 5.

Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program

Anna Kerpel-Fronius  1 , Zsuzsanna Monostori  1 , Gabor Kovacs  1 , Gyula Ostoros  1 , Istvan Horvath  2 , Diana Solymosi  1 , Orsolya Pipek  3 , Ferenc Szatmari  4 , Anita Kovacs  5 , Zsolt Markoczy  1 , Livia Rojko  1 , Ferenc Renyi-Vamos  1   6 , Konrad Hoetzenecker  7 , Krisztina Bogos  8 , Zsolt Megyesfalvi  1   6   7 , Balazs Dome  9   10   11
Affiliations

Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program

Anna Kerpel-Fronius et al. Eur Radiol. 2022 Jul.

Abstract

Objectives: Lung cancer (LC) kills more people than any other cancer in Hungary. Hence, there is a clear rationale for considering a national screening program. The HUNCHEST pilot program primarily aimed to investigate the feasibility of a population-based LC screening in Hungary, and determine the incidence and LC probability of solitary pulmonary nodules.

Methods: A total of 1890 participants were assigned to undergo low-dose CT (LDCT) screening, with intervals of 1 year between procedures. Depending on the volume, growth, and volume doubling time (VDT), screenings were defined as negative, indeterminate, or positive. Non-calcified lung nodules with a volume > 500 mm3 and/or a VDT < 400 days were considered positive. LC diagnosis was based on histology.

Results: At baseline, the percentage of negative, indeterminate, and positive tests was 81.2%, 15.1%, and 3.7%, respectively. The frequency of positive and indeterminate LDCT results was significantly higher in current smokers (vs. non-smokers or former smokers; p < 0.0001) and in individuals with COPD (vs. those without COPD, p < 0.001). In the first screening round, 1.2% (n = 23) of the participants had a malignant lesion, whereas altogether 1.5% (n = 29) of the individuals were diagnosed with LC. The overall positive predictive value of the positive tests was 31.6%. Most lung malignancies were diagnosed at an early stage (86.2% of all cases).

Conclusions: In terms of key characteristics, our prospective cohort study appears consistent to that of comparable studies. Altogether, the results of the HUNCHEST pilot program suggest that LDCT screening may facilitate early diagnosis and thus curative-intent treatment in LC.

Key points: • The HUNCHEST pilot study is the first nationwide low-dose CT screening program in Hungary. • In the first screening round, 1.2% of the participants had a malignant lesion, whereas altogether 1.5% of the individuals were diagnosed with lung cancer. • The overall positive predictive value of the positive tests in the HUNCHEST screening program was 31.6%.

Keywords: Early detection of cancer; Low-dose CT; Lung cancer; Screening program.

PubMed Disclaimer

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424 - DOI
    1. Neal RD, Sun F, Emery JD, Callister ME (2019) Lung cancer. BMJ 365:l1725 - DOI
    1. Ellis PM, Vandermeer R (2011) Delays in the diagnosis of lung cancer. J Thorac Dis 3:183–188
    1. Gutierrez A, Suh R, Abtin F, Genshaft S, Brown K (2013) Lung cancer screening. Semin Intervent Radiol 30:114–120
    1. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC (2009) Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 115:5007–5017 - DOI

MeSH terms

LinkOut - more resources